The use of whole immunoglobulin G (IgG) and F(ab')2 of the G-22 monoclonal antibody associated
To prevent these problems, we developed a new non viral DNA delivery system using cationic liposomes associated with tumor-specific monoclonal an tibody.',',') The present work investigated the effective ness of whole immunoglobulin G (IgG) and the F(ab')2 fragment of G-22 glioma-specific monoclonal antibody associated with cationic liposomes (im munoliposomes), and the effect of repeated exposure of these immunoliposomes for the transfer of a plas mid expressing the LacZ gene into various glioma cell lines.
Materials
and Methods
I. Cell lines
Rapid growing subclones (U251-MG-S and U251 SP-S) of human astrocytoma-glioblastoma cell lines, U251-MG and U251-SP, and human ependymoma cell lines, KMS-11104, were maintained in Eagle's minimum essential medium supplemented with 10% fetal calf serum, 0.1 mM non-essential amino acids, 5 mM L-glutamine, and antibiotics (streptomycin 100 µg/ml, penicillin 100 U/ml).
II. Antibody
A G-22 monoclonal antibody (mouse IgG monoclonal antibody) which specifically reacts with a surface antigen (G-22) of human glioma cells was prepared in our laboratory. This monoclonal an tibody reacted with 18 of 20 glioma cell lines and two of two melanoma cell lines. Extensive screening of other cell lines revealed no cross reactivity except for three cell lines for lung cancer.9) Recently, we confirmed that the antigen for the G-22 monoclonal antibody is CD44, which is overexpressed in human glioma cells.') The U251-MG-S and U251-SP-S cell lines possess the G-22 antigen, but the KMS-11104 cell line does not.
III. Preparation of cationic liposomes and im munoliposomes containing plasmid Cationic liposomes containing plasmid were pre pared by dissolving the positively charged lipid, N (a-trimethylammonioacetyl)-didodecyl-D-glutamate chloride (Sogo Pharmaceutical Co., Ltd., Tokyo), dilauroyl phosphatidylcholine (Sigma Chemical Co., St. Louis, Mo., U.S.A.), and dioleoyl phos phatidylethanolamine (Avanti Polar-Lipids, Inc., Pelham, Ala., U.S.A.) in the molar ratio of 1:2:2 (total amount l ,umol) in 0.5 ml of chloroform, and then evaporating the solvent. The lipid film was wet ted with 0.2 ml of phosphate-buffered saline (PBS) containing 20,ug of plasmid DNA (pCH110; Phar macia Co., Uppsala, Sweden), and then vortexed for 2 minutes. The volume of the suspension was adjusted to 0.5 ml with PBS.",") Immunoliposomes were prepared by a simplified method of mono clonal antibody-liposome association. Briefly, G-22 monoclonal antibody (2,ug per 1 pmol lipids) was added together with the plasmid DNA before vortex ing. Details of the preparation and characterization of cationic liposomes associated with G-22 mono clonal antibody has been reported elsewhere. 12) Uncaptured plasmid or antibody was removed by floatation on a Ficoll gradient.')
IV. Transfection of LacZ gene
Gene transfection into glioma cells was achieved by incubating the cells with the pCH110-entrapping cationic liposomes or immunoliposomes (15 nmol/ ml of lipids and 0.3 ,ug/ml of DNA) once or several times for a specific time. In one experiment , im munoliposomes were prepared using whole IgG or F(ab')2 of the G-22 monoclonal antibody to evaluate any difference between whole IgG and F(ab')2. The cells were exposed once to the cationic liposomes or immunoliposomes and then were incubated for 6 days. In another experiment, cationic liposomes and immunoliposomes prepared using F(ab')2 were added to the cells on Day 1 only, Days 1 and 2, or Days 1, 2, 3, and 4, and then incubated until Day 6 , to investigate the effect of repeated exposure . The cells were then scraped from the dish, collected by centrifugation, lysed by freeze-thawing three times in buffer (0.25 M sucrose, 10 mM Tris HCI, 10 mM ethylenediaminetetra-acetic acid, pH 7.4), and cen trifuged to remove the debris. The /3-galactosidase ac tivity in the cells was measured using o-nitrophenyl /i-D-galactopyranoside according to the protocol provided by Promerga Co., Madison, Wis., U.S.A. Proteins were measured by modified Lowry methods.4) Results Table 1 shows the results of the first experiment as sessing the difference between use of whole IgG and F(ab')2 of G-22 monoclonal antibody. Association of G-22 monoclonal antibody increased the activity of /3-galactosidase in G-22 positive cells (U251-MG-S and U251-SP-S cells), but there was no significant difference between immunoliposomes made with whole IgG and F(ab')2. In contrast, no increase of 8 galactosidase activity was observed in G-22 negative cells (KMS-II104). Table 2 shows the effect of single and repeated exposure of cationic liposomes or im munoliposomes. The /3-galactosidase activity after repeated exposure was greater than after a single ex posure and reached about 1.5 to 2-fold by the fourth exposure.
Discussion
Liposomes containing drugs or high molecular weight substances within the aqueous phase and/or in the lipid bilayer are regarded as a useful delivery system. Liposomes used as DNA delivery systems are expected to be non-toxic and non-immunogenic, and to achieve a high transfection efficiency. However, the transfection efficiency of ordinary liposomes is very low. and the density of the cell culture. Our cationic lipo somes are less toxic compared with Lipofectin. There fore, cationic liposomes should be used within op timal concentration.
Selective and efficient transfer of the gene to target cells is very important for clinical application. We associated the liposomes with a monoclonal an tibody (G-22 glioma-specific monoclonal antibody). However, the G-22 monoclonal antibody is a mouse IgG monoclonal antibody, and is difficult to apply repeatedly to humans. Use of the F(ab')2 fragment would reduce the immunogenicity of the antibody. Fortunately, we found no significant difference be tween immunoliposomes containing whole IgG and F(ab')2, and the association of the F(ab')2 to cation ic liposomes markedly increased the transfection efficiency. Furthermore, the transfection efficiency in creased about 2-fold by repeated exposure. These results indicate that repeated exposure of im munoliposomes has a high potential for the transfer of genes in clinical applications. All values are fl-galactosidase activity (mU/mg pro tein, n = 3). *p < 0.05, **p < 0.01 vs. Liposomes. #p < 0.05, ##p < 0.01 vs. Once. Empty lip: empty liposomes (15 nmol lipids/ml), Immunolip: im munoliposomes containing pCH 110 (15 nmol/ml of lipids, 0.3µg/ml of DNA, and G-22 monoclonal an tibody 2,ug per 1 4umol lipids), Liposomes: liposomes containing pCH110 (15 nmol/ml of lipids and 0.3 ,ug/ml of DNA).
